Sort by
Refine Your Search
-
The research group of Oliver Stegle looks for a postdoctoral researcher to join a collaborative project with GSK with the goal to apply computational methods to investigate the effects of rare
-
completed PhD in (bio)informatics or (neuro)immunology A completed Master’s degree in biology, biomedicine, bioinformatics, or data science Basic knowledge in cell culture, immunology, and molecular biology
-
from over 50 nations, it is the largest institute of the Max Planck Society. The Department of Theoretical and Computational Biophysics headed by Helmut Grubmüller is inviting applications for a PhD
-
Area of research: Scientific / postdoctoral posts Job description: Postdoc positions in Computational Health (f/m/x) 102675 Full time 39 hrs./week Neuherberg near Munich Partial Home Office possible
-
mathematics, computer science, physics, biomedical or electrical engineering or similar disciplines. Good programming expertise (Matlab, C++, Python or equivalent) and experience with the Linux operating system
-
international meetings and conferences Work closely together with other experimental and computational researchers in the group Assist with training and supervising other researchers (e.g. student assistants, BSc
-
are initially limited to three years. The Microbiome Dynamics (MBD) department contributes to the development of personalized microbiome-based strategies to aid in the detection, monitoring, treatment, and
-
evolution, molecular microbiology, synthetic communities, and computational biology. The project aims to pioneer a novel form of phage therapy by engineering prophages—phages integrated into bacterial genomes
-
metabolic disorders. Backed by a prestigious ERC Proof of Concept Grant, we are now looking for a Researcher or Postdoc (f/m/x) with a background in engineering or physics – and the ambition to help shape
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe